Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

BSEMBioStem Technologies, Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About BioStem Technologies, Inc. (BSEM)

BioStem Technologies, Inc. (BSEM) is a Biotechnology company headquartered in Pompano Beach, FL, United States whose shares trade over-the-counter on the Pink tier.

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

Products and services

BioStem Technologies produces innovative perinatal tissue-based allografts.

BSEM key facts

Ticker symbol
BSEM
Market tier
Pink
Headquarters
Pompano Beach, FL, United States
Country of incorporation
US
Year of incorporation
2009
Employees
20
Estimated market cap
$133.13M (as of Apr 9, 2025)
Shares outstanding
16,703,407
Reporting standard
Alternative Reporting Standard
Audit status
Unaudited
Fiscal year end
12/31
Latest filing
Quarterly Report (Sep 30, 2024)

BioStem Technologies, Inc. leadership

  • Jason Matuszewski — CEO, Co-Founder
  • Andrew VanVurst — COO, Co-Founder
  • Michael Fortunato — CFO
  • Shawn McCarrey — Chief Commercial Officer

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with B

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for BioStem Technologies, Inc. (BSEM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
2836 Center Port Circle
Pompano Beach, FL, 33064
United States

Company Leadership

Company Officers

Jason Matuszewski
CEO, Co-Founder
Andrew VanVurst
COO, Co-Founder
Michael Fortunato
CFO
Shawn McCarrey
Chief Commercial Officer

Social Media

Business Details

Stock Details

Loading modules...